Interventions for Patients With Alzheimer's Disease and Dysphagia
Launched by UNIVERSITY OF WISCONSIN, MADISON · Sep 21, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping patients with Alzheimer's disease and related types of dementia who have difficulty swallowing, a condition known as dysphagia. The goal is to develop special therapies that can improve their ability to swallow and reduce the risk of serious complications like pneumonia, which can occur when food or liquids enter the lungs instead of the stomach.
To participate in this study, individuals must be between 50 and 99 years old, speak English, and have a diagnosis of dementia or memory issues. They also need to have a caregiver who is involved in their care. Caregivers must be at least 18 years old, speak English, and be in regular contact with the patient. Participants will undergo various assessments and may receive new therapies designed to improve swallowing. This study is currently looking for volunteers, so if you or someone you know fits the criteria, it could be a valuable opportunity to contribute to research that aims to enhance the quality of life for those affected by these conditions.
Gender
ALL
Eligibility criteria
- Inclusion criteria (patients):
- • Age 50-99
- • English speaking
- • Diagnosis of dementia or cognitive impairment or memory loss
- • Clinical Dementia Rating (CDR) scale score between 0.5 and 2.0
- • Actively involved caregiver
- • Resides at home, assisted living facility, or long-term care facility
- • Inclusion criteria (caregivers)
- • English speaking
- • Age 18 and older
- • Contact with patient at least 1 time a week
- • Has access to a working telephone
- Exclusion criteria (patients):
- • Dementia due to cerebrovascular disease as primary cause
- • History of head and neck cancer or other structural deformity that can affect swallowing
- • Allergy to barium
- • Currently breastfeed or pregnant or planning to become pregnant
- Exclusion criteria (caregivers):
- • Lacks ability to give consent
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Nicole Rogus-Pulia, PhD, CCC-SLP
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials